Silencing of NLRP3 Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin

BACKGROUND: Ovarian cancer is a fatal gynecological malignancy. The resistance to chemotherapy in ovarian cancer treatment has been a thorny issue. This study is aimed at probing the molecular mechanism of cisplatin (DDP) resistance in ovarian cancer. METHODS: Bioinformatics analysis was conducted t...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Weijia, Zhao, Xibo, Zhang, Rujian, Xie, Jiabin, Zhang, Guangmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256449/
https://www.ncbi.nlm.nih.gov/pubmed/37304662
http://dx.doi.org/10.1155/2023/7700673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256449/
https://www.ncbi.nlm.nih.gov/pubmed/37304662
http://dx.doi.org/10.1155/2023/7700673

Ejemplares similares